Overexpressed transient receptor potential vanilloid 1 (TRPV1) in lung adenocarcinoma harbours a new opportunity for therapeutic targeting.
Nie Y, Feng F, Luo W, Sanders AJ, Zhang Y, Liang J, Chen C, Feng W, Gu W, Liao W, Wang W, Chen J, Zhang L, Jiang WG, Li J.
Nie Y, et al. Among authors: wang w.
Cancer Gene Ther. 2022 Oct;29(10):1405-1417. doi: 10.1038/s41417-022-00459-0. Epub 2022 Mar 30.
Cancer Gene Ther. 2022.
PMID: 35354949
Free PMC article.
Retracted.